Structure of the S100A4/myosin-IIA complex by Udupi A Ramagopal et al.
Ramagopal et al. BMC Structural Biology 2013, 13:31
http://www.biomedcentral.com/1472-6807/13/31RESEARCH ARTICLE Open AccessStructure of the S100A4/myosin-IIA complex
Udupi A Ramagopal1,3, Natalya G Dulyaninova1, Kristen M Varney2, Paul T Wilder2, Sridevi Nallamsetty2,
Michael Brenowitz1, David J Weber2, Steven C Almo1 and Anne R Bresnick1*Abstract
Background: S100A4, a member of the S100 family of Ca2+-binding proteins, modulates the motility of both
non-transformed and cancer cells by regulating the localization and stability of cellular protrusions. Biochemical
studies have demonstrated that S100A4 binds to the C-terminal end of the myosin-IIA heavy chain coiled-coil
and disassembles myosin-IIA filaments; however, the mechanism by which S100A4 mediates myosin-IIA
depolymerization is not well understood.
Results: We determined the X-ray crystal structure of the S100A4Δ8C/MIIA1908-1923 peptide complex, which showed
an asymmetric binding mode for the myosin-IIA peptide across the S100A4 dimer interface. This asymmetric
binding mode was confirmed in NMR studies using a spin-labeled myosin-IIA peptide. In addition, our NMR data
indicate that S100A4Δ8C binds the MIIA1908-1923 peptide in an orientation very similar to that observed for
wild-type S100A4. Studies of complex formation using a longer, dimeric myosin-IIA construct demonstrated that
S100A4 binding dissociates the two myosin-IIA polypeptide chains to form a complex composed of one S100A4
dimer and a single myosin-IIA polypeptide chain. This interaction is mediated, in part, by the instability of the region
of the myosin-IIA coiled-coil encompassing the S100A4 binding site.
Conclusion: The structure of the S100A4/MIIA1908-1923 peptide complex has revealed the overall architecture of this
assembly and the detailed atomic interactions that mediate S100A4 binding to the myosin-IIA heavy chain. These
structural studies support the idea that residues 1908–1923 of the myosin-IIA heavy chain represent a core
sequence for the S100A4/myosin-IIA complex. In addition, biophysical studies suggest that structural fluctuations
within the myosin-IIA coiled-coil may facilitate S100A4 docking onto a single myosin-IIA polypeptide chain.
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S100A4 is a member of the S100 family of small, dimeric,
EF-hand proteins. The S100 proteins, of which there are
21 family members in humans, primarily function as
Ca2+-sensors to modulate a multitude of biological pro-
cesses. The majority of S100 proteins are symmetric dimers
characterized by the presence of two EF-hand Ca2+-binding
loops per subunit; an N-terminal pseudo EF-hand (EF1)
comprising 14 residues and a C-terminal canonical EF-
hand (EF2) comprising 12 residues [1,2]. Calcium-binding
to the C-terminal EF-hand induces a structural rearrange-
ment involving the reorientation of helix 3 relative to
helix 4, resulting in the exposure of a hydrophobic cleft
that forms the binding surface for target proteins [3]. As* Correspondence: anne.bresnick@einstein.yu.edu
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distribution, and reproduction in any mediuma consequence, target binding for most S100 proteins is
strictly Ca2+-dependent.
The reported equilibrium dissociation constants (KD) for
the S100A4/Ca2+ interaction are relatively weak in the
absence of target (CaKD = 54 μM, EF1;
CaKD = 3.3 μM, EF2)
and increase approximately 10-fold in the presence of
target (CaKD = 3.6 μM, EF1;
CaKD = 0.26 μM, EF2) [4]. Stud-
ies with other S100 proteins suggest that the increased
Ca2+-binding affinity observed in the presence of target is
due to a ligand-induced reduction in S100 backbone and
side chain dynamics [5,6]. Localized target-mediated en-
hancement of the S100A4/Ca2+ interaction would permit
high intracellular S100A4 expression levels (e.g. 3 – 5 μM
[7]) without the depletion of free intracellular Ca2+ levels
and the disruption of Ca2+ oscillations. Proteomic and
localization studies have shown that S100A4 is enriched
in the pseudopodia of migrating cells [8-10]. Moreover a
S100A4 biosensor, which reports on Ca2+-bound S100A4,tral Ltd. This is an open access article distributed under the terms of the
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edge of polarized, migrating cells [11,12]. The enrichment of
S100A4 in protrusive structures is consistent with cell-based
functional studies demonstrating that S100A4 expression
modulates the migratory capacities of a broad range of cell
types [7,9,13,14]. Consistent with a role in regulating cell
motility, S100A4 has a number of reported cytoskeletal and
scaffold protein targets including non-muscle tropomyosin
2, liprin-β1 and non-muscle myosin-IIA [15-17].
Non-muscle cells can express three myosin-II heavy
chain isoforms (NMHC-IIA – MYH9, NMHC-IIB –
MYH10, NMHC-IIC – MYH14), which exhibit 64-80%
amino acid identity [18]. Each heavy chain is comprised of
an N-terminal motor domain that contains the ATP- and
actin-binding sites, an intermediate rod domain that di-
merizes to form an α-helical coiled-coil and a C-terminal
tailpiece. Despite the fairly high sequence conservation be-
tween the non-muscle myosin-II isoforms, studies with
assembly-competent myosin-II rod constructs, which lack
the myosin-II motor domain, demonstrate that S100A4
preferentially recognizes and disassembles myosin-IIA rods
[19,20]. Although recent reports indicate that S100A4
binds with high affinity to isolated myosin-IIC peptides,
S100A4-mediated regulation of myosin-IIC assembly has
not yet been examined [21]. For myosin-IIA, studies in
mammary adenocarcinoma cells have shown that the
S100A4/myosin-IIA interaction regulates the placement of
pseudopodial protrusions during chemotactic migration
[9]. In addition, macrophages with a genetic deletion for
S100A4 exhibit a myosin-IIA overassembly defect that re-
sults in impaired cellular protrusions and defective che-
motaxis [7]. Together these data support a role for the
S100A4/myosin-IIA interaction in modulating pseudopo-
dial structures, and as a consequence, chemotaxis. Consist-
ent with its function in modulating cellular motility,
S100A4 overexpression enhances the invasive capabilities
and metastatic dissemination of tumor cells [22-25].
We report the structure of the Ca2+-S100A4/myosin-
IIA complex, which demonstrates an unusual mode of
S100 protein target recognition, and is in accordance
with the recently described X-ray and NMR structures
of S100A4 bound to longer myosin-IIA peptides [21,26].
In addition, biophysical studies of the Ca2+-S100A4/
myosin-IIA complex suggest that instability of the myosin-
IIA coiled-coil is a contributing factor to S100A4-mediated
myosin-IIA depolymerization.
Results
Interaction of S100A4 with myosin-IIA
Our previous studies showed that S100A4 binds the
MIIA1904-1927 peptide with a stoichiometry of one pep-
tide per S100A4 dimer [27]. To examine the interaction
of S100A4 with a longer, more physiologically-relevant
myosin-IIA construct, we used MIIA1851-1960, whichcontains approximately 75 residues from the myosin-
IIA coiled-coil and the entire C-terminal tailpiece, and
encompasses the myosin-II extended assembly compe-
tence domain [28,29]. MIIA1851-1960 inhibits binding of the
MIIA1904-1927 peptide to S100A4 with an IC50 of 21.2 ±
2.0 nM (Figure 1A). Circular dichroism spectroscopy of
MIIA1851-1960 demonstrated that the peptide is primarily
α-helical as evidenced by characteristic minima at 222 and
208 nm (Figure 1B). An examination of the thermal stabil-
ity of MIIA1851-1960 revealed a relatively modest transition
midpoint (Tm) of 27°C for unfolding (Figure 1C), which
was reversible (data not shown). The dimeric state of
MIIA1851-1960 was confirmed by sedimentation equilib-
rium studies performed at 22°C (Table 1, Additional file 1:
Figure S1). While our thermal denaturation studies sug-
gest some MIIA1851-1960 monomer may be present, we did
not detect any monomer in sedimentation equilibrium
studies which were performed at higher protein concen-
trations than the thermal stability assays.
Sedimentation equilibrium studies of the S100A4/
MIIA1851-1960 complex using a 0.5:1 molar ratio of
MIIA1851-1960 dimer to S100A4 dimer revealed a species
with a weight-average molecular mass of 35,271 ± 425 Da,
which is consistent with the predicted mass of a S100A4
dimer with a single bound MIIA1851-1960 polypeptide chain
(35,592 Da) (Table 1). At a 1:1 molar ratio of MIIA1851-1960
dimer to 1 S100A4 dimer we observed a weight-average
molecular mass of 32,918 ± 490 Da, which likely corre-
sponds to a mixture of S100A4 dimers with a single bound
MIIA1851-1960 polypeptide chain and MIIA1851-1960 dimers
(Table 1).
Given the similarity in the molecular weights of
the S100A4 and MIIA1851-1960 dimers, the S100A4/
MIIA1851-1960 complex was further evaluated in sedi-
mentation velocity experiments where MIIA1851-1960 was
added to S100A4 at increasing molar ratios. The time de-
rivative plots for MIIA1851-1960 alone (Figure 2A) and
S100A4 alone (Additional file 1: Figure S2) showed that
each protein sedimented as a single homogenous species
with S values of 1.91 S and 1.9 S, respectively (Additional
file 1: Table S1). At a molar ratio of 0.5:1 MIIA1851-1960
dimer to S100A4 dimer there was a shift in the S value to
2.87 S consistent with the formation of an S100A4/
MIIA1851-1960 complex (Figure 2B). At increasing molar
ratios of MIIA1851-1960 dimer to S100A4 dimer (1:1, 1.5:1),
the best fit for the time derivative plot was to a two-
component model. This analysis indicated a peak at 2.89 S
that corresponded to the S100A4/MIIA1851-1960 complex
and a second peak at 1.9 S, which was consistent with the
presence of unperturbed MIIA1851-1960 dimer (Figure 2C
and 2D, Additional file 1: Table S1). The 2.89 S species
had an estimated mass of 31.5 ± 0.2 kDa. Given the ther-
mal instability of MIIA1851-1960 and our observation that
S100A4 forms a thermostable dimer at submicromolar
Figure 1 Properties of MIIA1851-1960. (A) Competition fluorescence
anisotropy measurements of S100A4 binding to MIIA1851-1960, IC50 =
21.2 ± 2.0 nM. Values represent the mean ± standard deviation from
two independent experiments. (B) Far-UV spectra of 40 μM MIIA1851-1960
monomer. (C) The thermal stability of MIIA1851-1960 (40 μM monomer
concentration) was assayed by monitoring the ellipticity at 222 nm.
Data represent the average of two independent experiments.
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sponds to a S100A4 dimer bound to a single MIIA1851-1960
polypeptide (calculated mass of 35,592 Da), which is consist-
ent with our previous chemical cross-linking studies [27].Characterization of S100A4Δ8C
Since we were unable to crystallize the wild-type full-length
S100A4 with myosin-IIA peptides and our previous struc-
tural studies demonstrated that at high protein concentra-
tions residues Glu91-Gln97 mediate interactions between
symmetry-related S100A4 dimers in the crystalline state
[4], we created a series of S100A4 C-terminal trunca-
tions (S100A4Δ3C, S100A4Δ4C, S100A4Δ6C, S100A4Δ7C,
S100A4Δ8C, S100A4Δ9C and S100A4Δ13C; where “Δ-
number” represents the number of residues deleted from
the S100A4 C-terminus) that were expected to reduce
S100A4 self-association. The S100A4Δ8C construct was
used since it exhibited minimal self-association in the
myosin-IIA peptide-bound state as assessed by dynamic
light scattering and NMR. The ability of S100A4Δ8C to
bind myosin-IIA was assessed in an anisotropy assay using
FITC-labeled MIIA1904-1927, which binds wild-type S100A4
with a KD of 0.26 ± 0.03 μM [27]. The measured disso-
ciation constant for S100A4Δ8C (0.51 ± 0.05 μM) was
comparable to that observed for the wild-type S100A4
(Figure 3A). In addition, binding was Ca2+-dependent as
no binding was observed in the presence of EGTA (data
not shown). Using assembly competent myosin-IIA rods
(MIIA1339−1960), we monitored the ability of S100A4Δ8C to
disassemble preformed myosin-IIA filaments. At a molar
stoichiometry of one S100A4Δ8C dimer per myosin-IIA
rod, S100A4Δ8C disassembled approximately 85% of the
myosin-IIA filaments, which was similar to the disassembly
observed in the presence of wild-type S100A4 (Figure 3B
and 3C).
X-ray Structures of S100A4Δ8C and the S100A4Δ8C/
MIIA1908-1923 peptide complex
Both the S100A4Δ8C and S100A4Δ8C/MIIA1908-1923 pep-
tide structures were determined by molecular replacement
using the native Ca2+-S100A4 structure (2Q91) truncated
at Glu91 as the search model [4] (Table 2). For the apo-
S100A4Δ8C structure there were four molecules in the
asymmetric unit (two S100A4Δ8C dimers), with continu-
ous density from residues Cys3-Gly92 for all molecules.
Residues in the favored, allowed and disallowed regions in
the Ramachandran plot account for 97.4%, 2.0% and 0.6%
of the total residues, respectively. The S100A4Δ8C/
MIIA1908-1923 structure contained a single S100A4 dimer
in the asymmetric unit with the MIIA1908-1923 peptide
bound asymmetrically across the dimer interface. The
electron density was continuous from residues Ala2-Gly92
for both molecules in the asymmetric unit, except for
residues Gly47-Arg49 (loop region between helix 2 and 3)
of subunit A, which were not modeled. Continuous differ-
ence density was observed in difference Fourier syntheses
(using Fo-Fc coefficients; contoured at 3σ) following the
first round of refinement, indicating the presence of
a highly ordered peptide, asymmetrically bound to the
Table 1 Summary of sedimentation equilibrium data
MIIA1851-1960: S100A4a Predicted MW (Da)b Experimental MW (Da)
MIIA1851-1960 24,795 25,651 ± 308
0.5 MIIA:1.0 S100A4 35,592 35,271 ± 425
1.0 MIIA:1.0 S100A4 32,893 32,918 ± 490
adimer: dimer ratio.
bPredicted molecular weights are based on sequence, which were confirmed by mass spectrometry; S100A4 dimer – 23,194.6 g/mol; MIIA1851-1960 monomer – 12,397.5 g/mol.
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vored, allowed and disallowed regions in the Ramachan-
dran plot account for 96.8%, 2.2% and 1.2% of the total
residues, respectively. The two residues in the disallowed
region, which deviate slightly from expected values, are
Arg49 (subunit B) from the disordered region and the C-
terminal Gly92.
The 1.54 Å structure of the S100A4/MIIA1908-1923 com-
plex revealed a single MIIA1908-1923 peptide binding across
the S100A4 dimer interface (Figure 4A). Electron density
was observed only for residues Asp1908-Leu1921 of the
MIIA1908-1923 peptide. As shown in Figure 5A, there is an
extensive H-bond network between myosin-IIA residues
Asn1911, Ser1915 and Lys1918, and Ser64 and Gln73 on
subunit B. In addition peptide residues Glu1913 and
Lys1920 form H-bonds with Gln73 and Lys57 of subunit
A. Met1910, Val1914, Leu1917 and Leu1921, which cor-
respond to the a and d positions of the myosin-IIA coiled-
coil (a – Val1914, Leu1921; d – Met1910, Leu1917), also
partcipate in S100A4 binding. Met1910 and Val1914
intercalate between helices 4 and 4′ at the S100A4 dimer
interface, while Leu1917 and Leu1921 insert into the
hydrophobic cleft of subunit A (Figure 5B).
The total buried surface area upon complex formation is
appproximately 1348 Å2, where 684 Å2 and 664 Å2 are
contributed by the MIIA1908-1923 peptide and S100A4, re-
spectively. Overall, nearly 380 contacts with a separation of
less than 5.0 Å and 8 hydrogen bonds are observed at
the myosin-IIA peptide and S100A4 interface. The calcu-
lated rms deviations for Cα atoms for residues 3–86 from
the Ca2+-bound S100A4 (2Q91) with the Ca2+-bound
S100A4Δ8C (4HSZ), the S100A4Δ8C/MIIA1908-1923 pep-
tide complex (4ETO) and the previously reported S100A4/
MIIA1893-1935 complex (3ZWH) were 1.2 Å, 1.3 Å and
1.1 Å, respectively; indicating that neither myosin-IIA
binding, nor the C-terminal truncation, alters the overall
conformation of the S100A4 dimer. The most significant
differences were observed in the loop connecting helices 2
and 3 (residues 45–52).
To examine myosin-IIA peptide binding to S100A4Δ8C
in solution, the MIIA1908-1923 peptide used in crystal-
lization studies was titrated into a 15N-labeled sample of
Ca2+-bound S100A4Δ8C. A comparison of these data to a
similar titration performed with wild-type S100A4 [4] re-
vealed that of the 44 correlations shown previously to shift
upon MIIA1908-1923 binding to wild-type S100A4, 34 ofthese chemical shift perturbations were observed in titra-
tions with S100A4Δ8C. These included residues in helix 1
(Cys3 Met12, Val13, Phe16, and Lys18), the pseudo-
EF-hand (Gly21 Asn30, Lys31), the hinge (Arg40, Glu41,
Leu42, Arg49, Thr50, and Asp51), helix 3 (Glu52, Phe55,
Asn56, Leu58, Met59, Ser60 and Leu62), the typical EF-
hand (Asp63, Ser64, Asn68, Gln73, and Glu74), helix 4
(Cys76, Val77, Met85, and Cys86), and the C-terminal tail
(Asn87, Gln97). Following the addition of the MIIA1908-1923
peptide, differences in chemical shift were also observed in
the 1H-15N correlations for Ser14, His17, Ser20, Phe27,
Gly47, Leu79, Ala83, Glu88, Phe89, Gly92 and for Phe93,
but these changes did not occur or were not the same as
perturbations found in titrations with wild-type S100A4. In
addition, there were fewer overlapping 1H-15N correlations
for the S100A4Δ8C/peptide complex since correlations
arising from residues 94–101 were absent in this S100A4
construct. Overall, these NMR data confirm that
S100A4Δ8C binds the MIIA1908-1923 peptide in a very simi-
lar structure/orientation in solution as observed for wild-
type S100A4.
Crystal packing interactions
An examination of the crystal packing interactions for
S100A4Δ8C shows that the C-terminal tail (residues
Glu88-Glu91) of subunit A interacts with the hydrophobic
cleft formed between helices 3 and 4 of the crystallograph-
ically related subunit B (Figure 6A) and vice versa. These
interactions result in the formation of rods of S100A4 di-
mers running parallel to the crystallographic b-axis for the
AB subunits and parallel to the ab diagonal for the CD
subunits (Additional file 1: Figure S3). The inter-dimer
contacts between the C-terminal tail of one S100A4 dimer
and the target binding cleft of the symmetry related mol-
ecule are primarily mediated by Phe89 and Phe90 of the
C-terminal tail, and residues Phe45, Leu46, Phe55, and
Leu58 in the hinge and helix 3 of the symmetry related
molecule (Figure 6B). A comparison of these S100A4
inter-dimer interactions with the S100A4/MIIA1893-1935
structure (3ZWH, Figure 6C) revealed that residues
Pro1927-Val1930 of the myosin-IIA peptide adopt a simi-
lar type I β-turn as S100A4 residues Glu88-Glu91, with
Phe1928 and Val1929 residing deep within the hydropho-
bic cavity formed by the hinge and helix 3 (Figure 6D). Al-
though the orientation of the S100A4 C-terminal helix
(Figure 4D, red) as it approaches the hydrophobic cleft is
Figure 2 Sedimentation velocity of the S100A4/MIIA1851-1960
complex. Plots of sedimentation coefficient distribution g*(s) versus
S20,w for MIIA
1851-1960 alone (A) and MIIA1851-1960/S100A4 mixtures at
molar ratios of 0.5:1 (B), 1:1 (C), and 1.5:1 (D) of MIIA1851-1960 dimer:
S100A4 dimer, which are represented by the open circles. The green
line is the best fit to MIIA1851-1960, the blue line is the best fit to the
S100A4 dimer/MIIA1851-1960 monomer complex and the red line is
the best fit for all species in the S100A4/MIIA1851-1960 mixtures.
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(Figure 4D, green), the Cα atoms for Glu88-Glu91 of
S100A4 and Pro1927-Val1930 of myosin-IIA have an
overall rms deviation of 0.921 Å; demonstrating that
when bound in the hydrophobic cleft, the C-terminal
tail of S100A4 and myosin-IIA present similar geomet-
ric and chemical features.
Solution studies of a larger S100A4/MIIA1893-1923 peptide
complex
Since MIIA1893-1923 bound S100A4 with a higher affinity
than MIIA1908-1923 [4], and exhibited better spectral prop-
erties than MIIA1908-1923, we examined this longer peptide
in NMR studies to further investigate the solution prop-
erties of the asymmetric binding mode observed for
myosin-IIA in the S100A4Δ8C/MIIA1908-1923 complex. As
expected for a complex with a dissociation constant in the
nanomolar range, MIIA1893-1923-bound S100A4 exhibited
resonances with slow exchange on the chemical shift time-
scale. This property resulted in spectra exhibiting narrow
linewidths, which is consistent with little, if any, broaden-
ing contributions from intermediate exchange. The 1H-15N
HSQC of the Ca2+-S100A4/MIIA1893-1923 complex showed
that peak doubling occurred for approximately two-thirds
of the observable 1H-15N correlations throughout all re-
gions of the protein (Figure 7). The resonance doubling
complicated the assignment of backbone and side chain
resonances, but it was still possible to sequence-specifically
assign all of the observed correlations using standard NMR
techniques. The observed peak doubling is consistent with
the binding mode of the shorter MIIA1908-1923 peptide in
our X-ray structure, in which peptide binding breaks the
symmetry of the S100A4 dimer interface that is observed
in the Ca2+-bound S100A4, resulting in two distinct elec-
tronic shielding environments for several residues.
A comparison of the 1H-15N HSQC spectra of the
S100A4/MIIA1893-1923 complex (peak doubling) to that
of the Ca2+-S100A4 (no peak doubling) revealed that it
was not possible to analyze the chemical shift perturba-
tions due to the ambiguities that peak doubling intro-
duced. To address this problem, a Proxyl spin-label was
covalently attached to the C-terminus of the MIIA1893-1923
peptide and the distance-dependent effects (1/r6) of para-
magnetic relaxation were mapped onto the Ca2+-S100A4
structure (Figure 8) [31]. At the lowest concentration of
Figure 3 S100A4Δ8 exhibits comparable myosin-IIA binding activity to wild-type S100A4. (A) Fluorescence anisotropy measurements of
S100A4Δ8 binding to FITC-MIIA1904-1927. Values represent the mean ± standard deviation from two independent experiments. A KD of 0.51 ±
0.05 μM was determined from the fit to a single site saturation binding curve. (B) Representative gel of myosin-IIA disassembly assays performed at a
ratio of 1:1 S100A4 dimer:myosin-IIA rod. 1 – myosin-IIA in the absence of S100A4; 2 – myosin-IIA in the presence of S100A4Δ8; 3 – myosin-IIA in the
presence of wild-type S100A4 (m= reaction mixture, s = supernatant). (C) Quantification of disassembly assays. Values represent the mean ± standard
deviation from two independent experiments.
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tions in cross-peak intensities were observed for resi-
dues in loop 1 (Asp25), the beginning of helix 3 (Asp51,
Glu52) and in the C-terminal loop (Lys100). These re-
laxation effects, plus those observed at the next titration
point (5.3 μM), were consistent with the C-terminus of
the MIIA1893-1923 peptide being located near residues in
helix 3 and the hinge (Leu46, Gly47, Asp51, Glu52;
Figure 9A and 9B). Although the cross-peak intensities
for residues Arg99 and Lys100 were also significantly
reduced by low MIIA1893-1923-Cys-Proxyl peptide con-
centrations, their exact positions in the Ca2+-S100A4
structure were uncertain since the C-terminal loop is
mobile in solution. In addition, these residues were not
observed in the Ca2+-S100A4 X-ray structure [4], which
is consistent with high structural plasticity and dynamic
behavior. Other residues in Ca2+-S100A4 were affected
to a lesser degree, and only at higher concentrations of
the spin-labeled peptide (i.e. ≥ 21 μM), including resi-
dues in helix 1 (Leu5, Glu6, Val13, Ser14, and His17),loop 1 (Lys26), the hinge (Lys48), and helix 3 (Thr50).
However, data at higher spin-labeled peptide concen-
trations were interpreted cautiously because of the po-
tential for outer sphere effects from free spin-labeled
peptide [31-33]. Altogether, these solution data support
the asymmetric binding mode for the myosin-IIA pep-
tide and indicate that the peptide can bind in either of
two orientations across the S100A4 dimer interface.
Discussion
To date, structural studies of S100-target complexes
have revealed a variety of binding modes with respect to
target recognition, which are typically characterized by
the formation of symmetric complexes with a 1:1 S100
subunit:target stoichiometry (Figure 10) [34-39]. For
S100B and S100A1-target complexes, target binding is
primarily mediated by interactions with the hydrophobic
cleft formed by helices 3 and 4 of the S100 protein, al-
though the orientation of the target peptide within the
hydrophobic cleft can vary significantly [34-36]. Other
Table 2 Crystallographic data and refinement statistics
S100A4Δ8C S100A4Δ8C/
MIIA1908-1923
PDB ID 4HSZ 4ETO
Source X29, BNL X4A, BNL
Wavelength (Å) 1.075 0.979
Resolution limits (Å) 46.9 – 2.25 50 – 1.54
Space group P1 P21
Unit cell (Å) a, b, c and α, β, γ (°) a = 28.80,
b = 34.36,






c = 32.86 and
β = 112.6
Number of observations 31076 87461
Number of unique reflections 14935 24461
aCompleteness (%) 96.4 (94.1) 99.6 (100)
Mean I/σI 19.6 (2.4) 27.8 (2.76)








Cutoff criteria I/σI 0 0
Protein/water atoms 2904/9 1530/86
Rwork/Rfree (5% of data) 0.228/0.277 0.209/0.251
cBonds (Å)/angles (°) 0.007/0.984 0.020/1.823
Mean B (Å2) 56.2 20.14
aParentheses indicate statistics for the high–resolution data bin for x–ray and
refinement data.
bRmerge = ∑hkl ∑i|I(hkl)i – < I(hkl) > |/∑hkl∑i < I(hkl)i >.
cValues indicate root–mean–square deviations in bond lengths, bond angles,
and B-factors of bonded atoms.
Figure 4 Structure of the S100A4Δ8C/MIIA1908-1923
complex. (A) Ribbon diagram of the S100A4Δ8C/MIIA1908-1923
complex showing the S100A4 subunits in green (subunit A) and
brown (subunit B) and the MIIA1908-1923 peptide in blue. (B) Refined
model of the S100A4Δ8C/MIIA1908-1923 peptide structure. The
myosin-IIA peptide (residues Asp1908-Leu1917) is shown in stick
representation superimposed onto the Fo-Fc electron density map,
contoured at 3.0σ.
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one S100 subunit and helix 1′ of the second S100 sub-
unit as observed for S100A10 and S100A11-target com-
plexes [38,39], and in the case of the S100A6/SIP
complex, target binding involves bidentate interactions
with the hydrophobic cleft of one S100 subunit and helix
1′ of the second S100 subunit [37]. The structure of the
S100A4Δ8C/MIIA1908-1923 peptide complex demon-
strates a fourth binding mode, in which the myosin-IIA
peptide binds asymmetrically across helices 4 and 4′ at
the S100A4 dimer interface. Asymmetric target binding
is emerging as a common feature amongst the S100 pro-
tein family as this binding mode is also observed for
AHNAK bound to the S100A10/annexin A2 complex
and SMARCA3 bound to the S100A10/annexin A2
complex [40-42].
The recent structures of S100A4 bound to longer
myosin-IIA peptides have demonstrated that the N- andC-termini of the peptide insert into the hydrophobic
clefts formed by helices 3 and 4 of each S100A4 subunit
to mediate high affinity binding [21,26]; however, our
structural studies indicate that a significantly shorter
myosin-IIA peptide is sufficient to promote an asymmet-
ric binding mode. A contributing factor to the asymmet-
ric disposition of the myosin-IIA peptide is that it makes
contacts with dimer-related residues on helices 4 and 4′
of each S100 subunit. In particular, Val77, Cys81 and
Met84 of each S100A4 subunit form interactions with
myosin-IIA that position the peptide nearly orthogonally
across the dimer interface. Our previous biochemical
studies support the contribution of these residues to
myosin-IIA binding as substitution of Cys81 with Ala or
Ser reduces S100A4 binding to myosin-IIA by 20- and
Figure 5 Interactions within the S100A4Δ8C/MIIA1908-1923 complex. Binding of the MIIA1908-1923 peptide (blue) to the S100A4Δ8C dimer
involves direct electrostatic interactions (A) and water mediated electrostatic interactions (not shown) as well as hydrophobic interactions
(B). Hydrogen bonds are shown as red dotted lines.
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http://www.biomedcentral.com/1472-6807/13/3155-fold, respectively, and disrupts S100A4-mediated
myosin-IIA disassembly [43].
In addition to crystallographic and biochemical data,
NMR data supports a model in which residues 1908 to
1923 of the myosin-IIA heavy chain represent the core
sequence for S100A4 recognition. In this regard, we ex-
amined whether this small peptide was sufficient to in-
duce what is termed the “final folding” event that occurs
upon S100 protein-target complex formation [6]. We ex-
amined whether conformational exchange in S100A4,
which is observed in the absence of bound target, could
be stabilized upon binding the MIIA1908-1923 peptide. As
found for other wild-type and mutant S100 proteins
[6,44], significant exchange broadening was observed
in the Ca2+-bound S100A4Δ8C. Notably, this exchange
broadening completely disappeared upon S100A4Δ8C/
MIIA1908-1923 complex formation (data not shown). As
with other S100 proteins, this behavior likely accounts
for the higher Ca2+-binding affinity observed for S100A4
when bound to MIIA1908-1923 [4]. This may be consid-
ered analogous to a “mini-folding” event in which target
binding shifts the S100A4 equilibrium population from a
highly dynamic, but weak Ca2+-binding state to a high
affinity Ca2+ binding state that is composed of an S100A4
population with a narrower distribution of dynamic fea-
tures. While the regulation of S100A4 protein dynamics
upon target binding will be the subject of future studies, it
is important to note that the MIIA1908-1923 peptide repre-
sents the core of the S100A4/myosin-IIA interaction since
it is adequately sized and positioned to eliminate con-
formational exchange upon binding either S100A4Δ8C or
wild-type protein [4]. Importantly, as most target-free
S100 proteins have a relatively low affinity for Ca2+ (i.e.,
versus bound to target) this allows for numerous S100
proteins to exist at high cellular concentrations (> 1 μM)without significantly depleting intracellular [Ca2+]free levels
and short-circuiting Ca2+ oscillations. Thus, reasonably
high S100A4 levels (e.g., 3–5 μM [7]) can be poised inside
the cell as myosin-IIA becomes available for complex
formation and downstream cytoskeletal modulation.
An interesting feature of the S100A4/myosin-IIA
complex is that myosin-IIA residues contributing to the
coiled-coil interface also mediate S100A4 binding. These
observations suggest a mechanism in which S100A4 bind-
ing induces partial unwinding of the myosin-IIA coiled-
coil, and thus promotes myosin-IIA filament disassembly.
The relatively low Tm (45°C) of the myosin-IIA rod (resi-
dues 1102–1960) [45], and the relative instability of the
coiled-coil region that encompasses the S100A4 binding
site suggests that this region of the myosin-IIA coiled-coil
likely undergoes significant thermally-driven structural
fluctuations (Figure 1C) [21,45]. Modest fluctuations in
the structure of the coiled-coil would allow initial docking
of S100A4 onto a single myosin-IIA polypeptide chain fol-
lowed by partial wrapping of the myosin-IIA heavy chain
across the S100A4 dimer and further unzipping of the
coiled-coil. The free myosin-IIA heavy chain would then
be available for subsequent capture by a second S100A4
dimer. Although turbidity studies with short myosin-IIA
rod constructs (residues 1712–1960 and 1761–1960) sup-
port a binding stoichiometry of one S100A4 dimer per
myosin-IIA polypeptide chain [21,46]; sedimentation assays
with longer myosin-IIA rod constructs (residues 1339–
1960) have shown that a stoichiometry of one S100A4
dimer to two myosin-IIA polypeptide chains (one myosin-
IIA heavy chain dimer) is sufficient to promote maximal
filament disassembly [19,43]. While S100A4 binds with
low nanomolar affinities to isolated myosin-IIA peptides
and short, relatively unstable myosin-IIA rod constructs,
binding to longer myosin-IIA rods or full-length myosin-
Figure 6 Self-association of S100A4Δ8 molecules in the crystal lattice. (A) The Ca2+-S100A4Δ8 dimer is shown with one red and one gray
subunit. The S100A4Δ8C dimers in the crystal are positioned such that the C-terminal tail of subunit B (red) inserts into the hydrophobic cleft
(subunit A-gray) of the adjacent S100A4 dimer. Similarly, the C-terminal tail of subunit A (gray) from the same adjacent dimer inserts into the
hydrophobic cleft on subunit B (red). (B) High magnification view of the boxed area in (A). Phe89 and Phe90 of the C-terminal tail are buried
inside the hydrophobic cleft of the symmetry-related molecule. (C) Superimposition of the S100A4/MIIA1893-1935 structure (3ZWH; peptide – green,
S100A4 dimer – orange and pistachio) onto the S100A4Δ8C/MIIA1908-1923 structure (peptide – blue, S100A4Δ8C dimer – gray and red). (D)
Myosin-IIA residues Pro1927-Val1930 (green) from the S100A4/MIIA1893-1935 structure (3ZWH) occupy the same region of the hydrophobic cleft as
the C-terminal tail of S100A4Δ8C. S100A4Δ8C residues Glu88-Glu91 (magenta) and myosin-IIA residues Pro1927-Val1930 (green) adopt a similar
conformation. Note that the S100A4 (red) and myosin-IIA (green) helices approach the hydrophobic cleft from opposite orientations.
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vations suggest that the loss of energy due to myosin-IIA
heavy chain unzipping can modulate S100A4 binding affin-
ity, as a significant fraction of the binding energy must be
used to drive the dissociation of the two polypeptide chains
in the myosin-IIA rod. Future studies directed at examin-
ing the requirement for the binding of one versus two
S100A4 dimers per myosin-IIA heavy chain dimer for
coiled-coil unzipping, as well as the reduction in free en-
ergy that occurs during unzipping will require the use of
longer and more stable myosin-IIA coiled-coil constructs.
This proposed model of S100A4-mediated myosin-II
heavy chain unzipping is analogous to the binding of
single-stranded DNA binding protein and ribosomal pro-
tein S1 to single-stranded DNA and RNA segments,respectively, that transiently form during thermal breath-
ing of the nucleic acid base pairs [48,49]. While the de-
tailed mechanisms of polymer unzipping associated with
these nucleic acid binding proteins will be different due
to their multi-domain nature and/or oligomeric state,
these biological systems provide a conceptual framework
for considering the mechanism of S100A4 coiled-coil
unzipping.
Conclusions
Direct visualization of the S100A4/myosin-IIA complex
has defined the chemical determinants required for
myosin-IIA binding and the overall organization of the
complex. These studies have identified residues 1908–1923
of the myosin-IIA heavy chain as a core sequence for
Figure 7 NMR assignments for MIIA1893-1923-bound Ca2+-S100A4. (A) A 1H-15N heteronuclear single quantum coherence spectrum (HSQC) of
MIIA1893-1923-bound S100A4 shown together with the resonance assignments. (B) Insert of the HSQC spectrum illustrating the assignments for the
most crowded region of the HSQC spectrum. The two weak contours labeled with an asterisk (*) were not assigned since they did not have
observable correlations to any other residues.
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these studies highlight the potential role of structural dy-
namics within the myosin-IIA coiled-coil and S100A4 in




For the production of the untagged, full-length protein,
the codon-optimized human S100A4 sequence was sub-
cloned into the Nde1/BamH1 sites of pET11b (Novagen).
The S100A4Δ8C deletion mutant (deletion of the C-
terminal eight amino acids) was subcloned into the Nde1/
BamH1 sites of pET11b. BL21(DE3)* cells were trans-
formed with the codon-optimized human wild-type or
Δ8C S100A4 and cultures were grown in Luria broth at
37°C to an OD600 of 0.8-1.0. Protein expression was in-
duced with 0.7 mM IPTG and the cultures were
grown for an additional 18–22 hrs at 27°C. The cells
were harvested at 8000 rpm for 10 min, and the cell
pellets were resuspended in lysis buffer (50 mM Tris
pH 7.5, 10% glycerol, 300 mM KCl, 5 mM DTT,
1 mM EDTA, 1 mM PMSF and 5 μg/ml each of chy-
mostatin, leupeptin, and pepstatin). The cell lysates
were frozen at −80°C, thawed on ice, and sonicated.
Following centrifugation of the lysate at 30000 g for30 min, ammonium sulfate was added to the super-
natant to 43% saturation, the sample was stirred for
20 min on ice and centrifuged at 30000 g for 10 min.
CaCl2 was added to the supernatant to a final
concentration of 2 mM, and the sample was applied
to a Phenyl-Sepharose column (GE Healthcare) equili-
brated in buffer P (20 mM Tris pH 7.5, 2 mM CaCl2,
300 mM KCl, 5 mM DTT, 1 mM EDTA, and 0.02%
NaN3) containing 25 g ammonium sulfate/100 ml.
The column was washed with 3 column volumes of
buffer P containing 25 g ammonium sulfate/100 ml
and then with 3 column volumes of buffer P without
ammonium sulfate, and S100A4 was eluted with
20 mM Tris pH 7.5, 5 mM EGTA, 2 mM DTT,
2 mM TCEP, 1 mM EDTA and 0.02% NaN3. Fractions
containing S100A4 were pooled and dialyzed against 2.0 L
of buffer Q (20 mM Tris pH 7.5, 2 mM DTT, 2 mM TCEP
and 0.02% NaN3). The dialyzed pool was applied to a Hi
Prep 16/10 QXL column (GE Healthcare) and the column
washed with 3 column volumes of buffer Q followed by
a 200 ml gradient of 0–0.5 M NaCl in buffer Q. The puri-
fied proteins were stored at −80°C. For crystallization,
S100A4 was gel-filtered on a HiLoad Superdex 75 26/60
column (GE Healthcare) and concentrated using aVivaspin
15R ultrafiltration spin column (Sartorius Stedium, Life
Technology).
Figure 8 1H-15N heteronuclear single quantum coherence spectrum (HSQC) of full-length Ca2+-S100A4 at 600 MHz. Black: S100A4 bound
to the MIIA1893-1923 peptide (0.25 mM S100A4 subunit and 0.75 mM MIIA1893-1923). Green: Following the addition of 42 μM MIIA1893-1923-Cys-Proxyl
peptide. Residues exhibiting a significant reduction in intensity are labeled.
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purified from bacterial cells grown in M9 media contain-









synthesized by Bio-Synthesis Inc. to a purity of >95% as
determined by HPLC and mass spectrometry. A 5 mM
stock solution of FITC-MIIA1904-1927 was prepared in
20 mM Tris pH 7.5, 150 mM KCl, 1 mM DTT and 0.02%
NaN3, aliquoted and stored at −80°C. The concentration
of the FITC-MIIA1904-1927 peptide was determined using
the extinction coefficient for FITC. The concentrations of
the MIIA1908-1923 and MIIA1904-1927 peptides were deter-
mined by quantitative amino acid analysis (Keck Biotech-
nology Resource Laboratory at Yale University, New
Haven, CT). A 25 mM stock solution of MIIA1908-1923 was
prepared in 10 mM Tris pH 7.5, 10 mM NaCl, and 0.02%






Cys), which contained an additional Cys on the C-terminus
were made by solid-state peptide synthesis to a purityof >95% as determined by HPLC and mass spectrometry.
Stock peptide solutions were prepared in metal free double
distilled H2O and concentrations were determined by
quantitative amino acid analysis (BioSynthesis Inc.).
Myosin-IIA proteins
A codon-optimized C-terminal fragment of the human
myosin-IIA heavy chain that corresponds to residues 1851–
1960 (MIIA1851-1960) was cloned into the NdeI/EcoR1 sites
of pET26b and expressed in BL21(DE3)* cells using TB
autoinducing media. MIIA1851-1960 was purified by sequen-
tial chromatography on High Q Sepharose anion exchange
(GE Healthcare) and Bio-Scale Ceramic Hydroxyapatite
Type I (Bio-Rad) columns as described previously [4] and
then gel-filtered on a Sephacryl S200 26/60 column (GE
Healthcare). The MIIA1851-1960 protein concentration was
determined using the Bradford protein assay (Bio-Rad) and
a MIIA1851-1960 standard of known concentration. The con-
centration of the MIIA1851-1960 standard was determined by
amino acid analysis (Keck Biotechnology Resource Labora-
tory at Yale University, New Haven, CT). The mass of
MIIA1851-1960 was confirmed by mass spectrometry.
Peptide spin labeling
For the MIIA1893-1923-Cys peptide, 25 μl of a 29.77 mM
stock peptide solution was added to 92 μl of metal free
(Chelex-100 treated) double distilled H2O, 20 μl 500 mM
Figure 9 Paramagnetic relaxation effects observed for 1H-15N
HSQC correlations of Ca2+-S100A4 in a titration with a MIIA1893-
1923 peptide spin-labeled at its C-terminus. (A) 1H-15N HSQC
correlations for Glu23, Asp51, and Lys100 of Ca2+-bound S100A4 in
the presence of increasing amounts of spin-labeled MIIA1893-1923
peptide (0, 2.6, 5.3, 11, 21, 42, and 95 μM). (B) Ribbon diagram of
Ca2+-bound S100A4 (PDB 2Q91) with residues affected by the spin
label highlighted in blue. Residues exhibiting the strongest effects
are shown as spheres. Arg99 and Lys100 are not shown on the
ribbon diagram since these residues are not observed in the X-ray
structure due to the mobility of the C-terminal loop [4].
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washed immobilized TCEP disulfide reducing gel (Pierce)
for >1 hour at room temperature. The beads containing
the immobilized TCEP and other particulates were re-
moved using a 0.45 μm Nanosep MF GHP centrifugal de-
vice (Pall Life Sciences) before the addition of 61 μl freshly
prepared 50 mg/ml 3-maleimido-Proxyl (Sigma-Aldrich)
in DMSO. Purification of the Proxyl-labeled peptide
(MIIA1893-1923-Cys-Proxyl) was performed by separation of
the unlabeled and labeled peptides on a C18 column using
a 0-90% acetonitrile gradient and monitoring at 214 nm
and 280 nm. The unlabeled peptide does not absorb at
280 nm, whereas the Proxyl-labeled peptide has an extinc-
tion coefficient of 500 M-1 cm-1 at 280 nm. The reaction
was complete in 4 hours at room temperature and further
incubation resulted in the production of second labeled
form of the peptide, likely from the slower modification of
methionine by the 3-maleimido- Proxyl [50]. The purified
MIIA1893-1923-Cys-Proxyl peptide (>99%) was resuspended
in D6-DMSO (Cambridge Isotopes Labs) and the peptide
concentration was determined using the extinction coeffi-
cient of the Proxyl label.S100A4 crystallization
S100A4Δ8C was freshly dialyzed against 20 mM Tris
pH 7.5, 150 mM KCl, 1 mM DTT, 0.02% NaN3, and
0.5 mM CaCl2 and clarified by ultracentrifugation at
80000 rpm for 10 minutes at 22°C in TLA 120.2 rotor.
S100A4 protein concentrations were determined using
the Bradford protein assay (Bio-Rad) and a S100A4
standard of known concentration. The concentration of
the S100A4 standard was determined by quantitative
amino acid analysis (Keck Biotechnology Resource La-
boratory at Yale University, New Haven, CT).
S100A4Δ8C was mixed with the MIIA1908-1923 peptide in
1:1 ratio of S100A4 subunit per peptide and incubated for
1 hour at room temperature. Diffraction quality crystals of
the complex were obtained by sitting drop vapor diffusion
at 20°C by mixing 1 μl of the protein complex (15.5 mg/
mL) with 1 μl of reservoir solution containing 0.1 M
HEPES pH 7.0 and 30% (v/v) Jeffamine M-600. Rod-
shaped crystals appeared after 3–4 days, which were flash
cooled in liquid nitrogen without any additional cryo-
protectant. Ca2+-bound S100A4Δ8C crystals were grown
using a similar protocol except the reservoir solution con-
tained 0.1 M HEPES pH 7.0, 0.1 M magnesium chloride,
and 15% PEG 4000. Thin-plate shaped crystals appeared in
one week and the crystals were harvested with mother
liquor supplemented with 15% glycerol as a cryopro-
tectant for flash-cooling. Data were collected at beam-
lines X4A and X29A (Brookhaven National laboratory) for
the S100A4Δ8C/MIIA1908-1923 peptide and Ca2+-bound
S100A4Δ8C crystals, respectively. Data were integrated and
scaled with HKL2000 [51]. The S100A4Δ8C/MIIA1908-1923
peptide complex crystals exhibited diffraction consistent
with the space group P21 (a = 30.28 Å, b = 91.99 Å, c =
32.86 Å, β = 112.6°) and apo-S100A4Δ8C crystals were tri-
clinic with space group P1 (a = 28.80 Å, b = 34.36 Å, c =
95.31 Å, α = 95.48°, β = 95.30°, γ = 114.82°).
Structure determination
The S100A4Δ8C and S100A4Δ8C/MIIA1908-1923 peptide
structures were determined by molecular replacement to
2.5 Å and 1.54 Å, respectively using the program MOL-
REP [52] and the Ca2+-S100A4 structure (PDB 2Q91) as
the search model. Iterative cycles of model building and
refinement were performed using COOT [53] and
REFMAC5 [54]. For the S100A4Δ8C/MIIA1908-1923 pep-
tide structure, continuous difference density was observed
in the Fo-Fc map contoured at the 3σ level following the
first round of refinement, indicating the presence of a
highly ordered peptide, asymmetrically bound to the
S100A4 dimer. The final S100A4Δ8C/MIIA1908-1923 pep-
tide model contained 2 S100A4 subunit chains (Ala2-
Gly92) (named A and B), 1 myosin-IIA peptide, 4 calcium
ions and 86 water molecules, resulting in a Rwork and
Rfree of 20.9% and 25.1%, respectively (PDB 4ETO). The
Figure 10 Comparison of six S100-target complexes. (A) S100B-p53 (1DT7); (B) S100B-NDR kinase (1PSB); (C) S100A1-TRTK12 (2KBM);
(D) S100A10-annexin2 (1BT6); (E) S100A6-SIP (2JTT) and (F) S100A10-annexin2-AHNAK (4DRW). The S100 subunits are shown in green and tan,
and the peptide ligand in blue. For the S100A10-annexin2-AHNAK ternary complex, the annexin2 peptide is shown in orange.
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chains (Cys3-Gly92), 8 calcium ions and 10 water mole-
cules with a Rwork and Rfree of 22.8% and 27.7%, respect-
ively (PDB 4HSZ).
Anisotropy assays
Fluorescence anisotropy measurements were performed
at 22°C using a Fluoromax-3-spectrofluorometer (Jobin
Yvon). Individual reactions (200 μl) contained 50 nM
FITC-MIIA1904-1927 and 0–30 μM S100A4Δ8C dimer in
20 mM Tris pH 7.5, 150 mM KCl, 1 mM DTT, 0.02%
NaN3, 0.5 mM CaCl2 and 0.5 mg/ml BSA. For competi-
tion anisotropy measurements individual reactions con-
tained 50 nM FITC-MIIA1904-1927, 0.3 μM S100A4
dimer and 0–10 μM MIIA1851-1960 dimer as described
above. Controls included experiments representing
maximum anisotropy (15 μM wild-type S100A4 and
S100A4Δ8C, 50 nM FITC-MIIA1904-1927 and calcium)
and minimum anisotropy (in the absence of S100A4
and in the presence of S100A4 and 5 mM EGTA). An-
isotropy was measured using excitation and emission
wavelengths of 490 nm and 520 nm, respectively. Mea-
surements were acquired at the magic angle of 55° be-
tween the vectors of polarization of the excitation and
emission light using a G factor of 0.634 as determined
previously for FITC on this instrument. For measure-
ments of S100A4Δ8C binding, data from two independ-
ent experiments were plotted using Graphpad Prism v5,
and the dissociation constant was calculated by fitting
to a single site saturation binding equation allowing fora floating Ymin value [11]. For competition anisotropy
assays data from two independent experiments were
plotted using Graphpad Prism v5, and fit to a sigmoidal
dose–response equation with a variable slope to obtain
the IC50 value.
Promotion of disassembly assays
Assays comparing the ability of wild-type and the Δ8C
S100A4 to depolymerize assembled myosin-IIA rods were
performed as described in Li et al. [19], using 1.5 μM
S100A4 dimer and 1.5 μM myosin-IIA rod dimer in
20 mM Tris–HCl pH 7.5, 150 mM NaCl, 1 mM DTT,
2 mM MgCl2, 0.5 mM CaCl2, and 0.02% NaN3. Reaction
mixtures (100 μl) were incubated for 2 hr at 22°C and then
centrifuged at 80,000 rpm (175000 g) for 10 min at 25°C in
a TL-100 ultracentrifuge (Beckman). Samples of the reac-
tion mixtures and supernatants were separated on a 12%
Tris-Tricine SDS-polyacrylamide gel. Coomassie-stained
gels were scanned and the extent of myosin-IIA poly-
merization was quantified by densitometry and analyzed
with the ImageQuant version 5.2.
NMR spectroscopy
The Ca2+-loaded S100A4Δ8C/MIIA1908-1923 and S100A4/
MIIA1893-1923 samples were prepared as described previ-
ously [4] and contained 0.25 mM S100A4 subunit and
0.75 mM MIIA peptide in 10 mM CaCl2, 0.35 mM NaN3,
10 mM NaCl, 0.1 mM EDTA, 5 mM DTT, 10% D2O, and
10 mM Tris, and the pH was brought to 6.5 with HCl.
The MIIA1893-1923-Cys-Proxyl peptide was titrated into
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each addition via the 15N- HSQC signal. HSQC NMR data
were collected at 37°C with a 600 MHz (600.13 MHz for
protons) Bruker DMX NMR spectrometer equipped with
pulsed-field gradients, four frequency channels, and a
triple resonance, z-axis gradient cryogenic probe, Data
were processed with NMRPipe [55], and proton chemical
shifts were reported with respect to the H2O or HDO sig-
nal taken as 4.658 ppm relative to external trimethylsilyl-
propionic acid (0.0 ppm). The 15 N chemical shifts were
indirectly referenced as described previously using the fol-
lowing ratio of the zero-point frequency: 0.10132905
for 15 N to 1H [56].Circular dichroism spectroscopy
MIIA1851-1960 was dialyzed into 20 mM Tris pH 7.5,
150 mM KCl, 0.5 mM CaCl2, 0.02% NaN3 and clarified
by ultracentrifugation at 80,000 rpm for 10 minutes at
4°C in TLA 120.2 rotor. MIIA1851-1960 (40 μM monomer
concentration) was transferred to a 1 mm path-length
quartz cuvette and scanned in Jasco J-815 Spectrometer
equipped with a PFD-425 temperature controller. Spec-
tra from 190 to 260 nm were obtained at 22°C using a
scan speed of 100 nm/minute, a 1 nm bandwidth, and a
sensitivity of 100 mdeg. Thermal melt curves were ob-
tained by monitoring ellipticity at 222 nm while the
sample temperature was increased from 2 – 85°C in 2°C
intervals at a rate of 60°C/h, using a 1 nm bandwidth.
The data were fit to a sigmoidal dose–response with a
variable slope using Graphpad Prism v5.Analytical ultracentrifugation
Sedimentation equilibrium and velocity experiments
were conducted at 22°C in a Beckman XL-I analytical
ultracentrifuge using a Ti60 rotor and Raleigh interfer-
ence optics. Wild-type S100A4 and MIIA1851-1960 were
dialyzed into 20 mM Tris pH 7.5, 150 mM KCl, 0.5 mM
CaCl2, 1 mM TCEP and 0.02% NaN3 and clarified by
ultracentrifugation at 80,000 rpm for 10 minutes at
4°C in TLA 120.2 rotor. Sedimentation equilibrium ana-
lysis of MIIA1851-1960 and S100A4 was conducted in six
channel centerpieces by sequentially equilibrating the
protein at three concentrations for 24 hr at 12,000,
20,000 and 28,000 rpm and globally analyzing the
data using HeteroAnalysis v1.1.44 (James L. Cole and
Jeffrey W. Lary). The sedimentation velocity experi-
ments were conducted at 53,000 rpm using double
sector centerpieces and analyzed using DCDT + v2.4.0
[57,58]. The best-fit parameters and their 95% joint
confidence intervals are reported. The calculated masses
of the wild-type S100A4 and MIIA1851-1960 monomers
are 11,597.3 and 12,397.5 Da, respectively. Values of
ν-bar = 0.715 for S100A4/MIIA851-1960 and 0.735 forS100A4, ρ = 1.0059, μ = 1.00586 cp were calculated using
Sednterp v1.06 (Hayes, B., T. Laue & J. Philo, Sedi-
mentation Interpretation Program. 2003, University of
New Hampshire) from the amino acid and buffer composi-
tions, respectively.
Additional file
Additional file 1: Table S1. Summary of Sedimentation Velocity Data.
Figure S1: Representative scans and residuals for sedimentation equilibrium
measurements of MIIA1851-1960. The solid lines represent the best fit from a
global nonlinear least-squares analysis of data obtained at 20,000 and
28,000 rpm. (A) 0.5 mg/ml, (B) 1.0 mg/ml and (C) 2.5 mg/ml MIIA1851-1960
(40.3, 80.6 and 201.7 μM monomer concentration). Figure S2: Sedimentation
velocity of the S100A4/MIIA1851-1960 complex. Plots of sedimentation coefficient
distribution g*(s) versus S20,w for S100A4 alone (A) and MIIA
1851-1960/S100A4
mixtures at a molar ratio of 0.25:1, MIIA1851-1960 dimer:S100A4 dimer. The green
line is the best fit to the S100A4 dimer, the blue line is the best fit to the
S100A4 dimer/MIIA1851-1960 monomer complex and the red line is the best fit
for all species in the S100A4/MIIA1851-1960 mixtures. Figure S3: Interaction of
S100A4Δ8 molecules in the crystal lattice.
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